Alpha Pro Tech Ltd. - 10-Q Summary (Period Ended Sep 30, 2009)
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2009. Alpha Pro Tech Ltd. develops, manufactures, and markets disposable protective apparel, building supply products, and infection control products. The company operates through three segments: Disposable Protective Apparel, Building Supply, and Infection Control. The financial statements are unaudited.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2009 | Nine Months Ended Sep 30, 2009 |
|---|---|---|
| Net Sales | $16,889,000 | $40,763,000 |
| Gross Margin | $8,209,000 (48.6%) | $19,199,000 (47.1%) |
| Net Income | $2,822,000 | $5,505,000 |
| Diluted EPS | $0.12 | $0.24 |
| Cash and Equivalents | $9,084,000 (as of Sep 30, 2009) | |
| Working Capital | $25,395,000 (as of Sep 30, 2009) | |
| Debt | $0 (No borrowings under $3.5M credit facility) | |
| Operating Cash Flow (9mo) | $6,815,000 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 65.3% for the quarter and 52.9% for the nine months compared to 2008. This was driven by a 290.1% surge in the Infection Control segment and a 67.7% increase in the Building Supply segment.
- Profitability: Net income increased 278.8% for the quarter and 333.8% for the nine months. Operating margins improved significantly due to favorable product mix shifts toward higher-margin infection control products.
- Segment Performance:
- Infection Control: Sales jumped due to H1N1 pandemic demand, specifically N-95 respirator masks and eye shields.
- Building Supply: Sales reached a quarterly record, driven by synthetic roof underlayment and house wrap.
- Disposable Protective Apparel: Sales decreased slightly (3.2%) in the quarter due to supply chain delays from Asia related to high global demand.
- Liquidity: Cash increased 98.4% year-over-year to $9.1M. Accounts receivable increased 90.4% due to sales volume, while inventory decreased 21.7% primarily in the Building Supply segment.
Outlook, Risks, and Management Commentary
- Outlook: Management expects N-95 respirator mask sales to continue growing significantly in the fourth quarter and remain stronger than normal due to H1N1 concerns. The company anticipates an effective tax rate of 36%-37% for 2009.
- Capital Allocation: The company repurchased 1,554,900 shares of common stock for $2.1M during the nine-month period. Approximately $862,000 remains available under the repurchase program.
- Risks:
- Supply Chain: Reliance on subcontractors in China and Mexico exposes the company to foreign currency fluctuations and potential delays.
- Market Dependence: Significant revenue growth is currently tied to the H1N1 pandemic; future performance depends on the duration of this demand.
- Concentration: A significant portion of sales comes from a limited number of distributors.
- Unusual Items: SG&A expenses included a $225,000 severance payment for a former executive and increased executive bonuses ($959,000 accrued for the nine months) tied to pre-tax profits.
Investor Verification Checklist
- Verify the sustainability of Infection Control sales post-H1N1 pandemic.
- Monitor accounts receivable days sales outstanding (49 days) given the 90% increase in receivables.
- Review the impact of supply chain delays on the Disposable Protective Apparel segment.
- Confirm the status of the $3.5M credit facility and any potential future borrowing needs.
- Assess the long-term growth trajectory of the Building Supply segment in a weak housing market.